CN Patent
CN119735586A — 一种恩格列净晶型iii及其制备方法
Assigned to Jinan Boyang Analytical Instrument Co.,Ltd. · Expires 2025-04-01 · 1y expired
What this patent protects
本发明属于医药技术领域,具体涉及恩格列净的新晶型及其制备方法。所述恩格列净的新晶型的X射线粉末衍射图谱如图1所示。本发明提供了恩格列净新晶型III,在稳定性和溶解度上优于其他晶型,在制药工业中前景优异。本发明还提供了5种新晶型相应的制备方法,所述制备方法简便,易于工业应用,采用相应的制备方法实施例1所获得新晶型的收率均可达到90%以上。
USPTO Abstract
本发明属于医药技术领域,具体涉及恩格列净的新晶型及其制备方法。所述恩格列净的新晶型的X射线粉末衍射图谱如图1所示。本发明提供了恩格列净新晶型III,在稳定性和溶解度上优于其他晶型,在制药工业中前景优异。本发明还提供了5种新晶型相应的制备方法,所述制备方法简便,易于工业应用,采用相应的制备方法实施例1所获得新晶型的收率均可达到90%以上。
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.